By Bill Peckham
On Thursday Baxter reported third quarter results and activity highlights including:
Filing an Investigational Device Exemption (IDE) with the U.S. Food and Drug Administration (FDA) to begin a clinical study to collect safety and effectiveness data required for a 510(k) application for a new home hemodialysis system.
A new home hemodialysis system. How exciting.





I thought this was going to be rolled out this year. Drag drag drag your feet, let the patients wait....
Posted by: Brian Steele-Sierk | October 18, 2009 at 09:00 PM
An announcement to gain more investors.
Posted by: Zach | October 18, 2009 at 10:03 PM
what are the main steps of dialysis?
Posted by: boo | October 20, 2009 at 10:46 AM
A great source for basic dialysis information is Kidney School.
Posted by: Bill Peckham | October 20, 2009 at 08:38 PM